- Home
- FGI vs ACXP Comparison
FGI vs ACXP Comparison
Compare FGI & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- ACXP
- Stock Information
- Founded
- FGI 1987
- ACXP 2017
- Country
- FGI United States
- ACXP United States
- Employees
- FGI N/A
- ACXP N/A
- Industry
- FGI Industrial Specialties
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- ACXP Health Care
- Exchange
- FGI Nasdaq
- ACXP Nasdaq
- Market Cap
- FGI 7.9M
- ACXP 9.1M
- IPO Year
- FGI 2022
- ACXP 2021
- Fundamental
- Price
- FGI $3.85
- ACXP $4.09
- Analyst Decision
- FGI
- ACXP Strong Buy
- Analyst Count
- FGI 0
- ACXP 3
- Target Price
- FGI N/A
- ACXP $143.67
- AVG Volume (30 Days)
- FGI 45.5K
- ACXP 85.5K
- Earning Date
- FGI 08-11-2025
- ACXP 08-12-2025
- Dividend Yield
- FGI N/A
- ACXP N/A
- EPS Growth
- FGI N/A
- ACXP N/A
- EPS
- FGI N/A
- ACXP N/A
- Revenue
- FGI $135,904,413.00
- ACXP N/A
- Revenue This Year
- FGI $5.57
- ACXP N/A
- Revenue Next Year
- FGI $8.02
- ACXP N/A
- P/E Ratio
- FGI N/A
- ACXP N/A
- Revenue Growth
- FGI 12.30
- ACXP N/A
- 52 Week Low
- FGI $2.28
- ACXP $3.80
- 52 Week High
- FGI $5.50
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- FGI 47.07
- ACXP 33.77
- Support Level
- FGI $3.52
- ACXP $3.83
- Resistance Level
- FGI $4.16
- ACXP $7.15
- Average True Range (ATR)
- FGI 0.27
- ACXP 0.58
- MACD
- FGI -0.02
- ACXP 0.05
- Stochastic Oscillator
- FGI 39.47
- ACXP 7.83
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.